MARKET

XBI

XBI

State Street® SPDR® S&P® Biotech ETF
NYSEARCA
164.28
+1.31
+0.80%
Pre Market: 164.14 -0.14 -0.09% 04:11 07/10 EDT
OPEN
162.80
PREV CLOSE
162.97
HIGH
165.71
LOW
162.80
VOLUME
480
TURNOVER
344.82M
52 WEEK HIGH
165.71
52 WEEK LOW
82.64
TOTAL ASSET
11.03B
YTD YIELD
87.79%
1D
5D
1M
3M
1Y
5Y
1D
Healthcare Investing: Finding Growth Beyond Pharmaceuticals
Seeking Alpha · 5h ago
Stocks Look Shaky, But This Sector is Booming (Biotech)
NASDAQ · 18h ago
Biotech rally rests on fundamentals, M&A appetite, says ROTY's Faison
Seeking Alpha · 1d ago
Weekly Report: what happened at XBI last week (0629-0703)?
Weekly Report · 4d ago
NervGen Pharma: I Think The Biggest Risks Are Now Behind It
Seeking Alpha · 07/02 16:25
XBI, APGE, KYMR, TWST: Large Inflows Detected at ETF
NASDAQ · 07/02 15:09
BTIG’s top small and mid-cap stocks for H2, ranked by SA Quant
Seeking Alpha · 07/01 16:32
BTIG’s top large-cap stocks for the second half of 2026, ranked by SA Quant
Seeking Alpha · 07/01 16:16
More
Profile
Fund Name
State Street® SPDR® S&P® Biotech ETF
Inception Date
2006-01-31
Benchmark
S&P 500 (TR) (1970)
Advisor Company
SPDR State Street Investment Management
Custodian
State Street Bank & Trust Co
Manager
Michael Feehily, Emiliano Rabinovich, Raymond Donofrio, Karl Schneider